PDMR Notification & Director Shareholding (1765125)
03 Novembro 2023 - 1:30PM
UK Regulatory
Arix Bioscience PLC (ARIX)
PDMR Notification & Director Shareholding
03-Nov-2023 / 16:30 GMT/BST
=----------------------------------------------------------------------------------------------------------------------
Arix Bioscience plc
("Company")
PDMR Notification & Director Shareholding
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons
closely associated with them
The Company has been notified that Peregrine Moncreiffe, Director and Chairman of the Company purchased 40,000 Ordinary
shares of 0.001 pence each in the Company ("Shares") on 3rd November 2023 at a price of GBP1.15 per share.
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name
Peregrine Moncreiffe
2 Reason for the notification
a) Position/status Non-Executive Director and Chair of the
Board
b) Initial notification /Amendment
Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction
monitor
a) Name
Arix Bioscience plc
b) LEI 213800OVT3AHQCXNIX43
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Arix Bioscience plc Ordinary shares of 0.001
pence each
Identification code GB00BD045071
b) Nature of the transaction
Share purchase
Price(s) and volume(s) Price(s)GBP Volume(s)
c) 40,000
1.15
Aggregated information
d)
- Aggregated volume 40,000
- Price GBP46,000.00
e) Date of the transaction
3 November 2023
f) Place of the transaction
Outside a trading venue
For further information please contact: Kin Company Secretarial
Limited, Company Secretary +44 20 8819 6486
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a Regulatory Announcement, transmitted by EQS
Group. The issuer is solely responsible for the content of this
announcement.
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD045071
Category Code: DSH
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 282725
EQS News ID: 1765125
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1765125&application_name=news
(END) Dow Jones Newswires
November 03, 2023 12:30 ET (16:30 GMT)
Arix Bioscience (LSE:ARIX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Arix Bioscience (LSE:ARIX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025